Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://zaynakjg585763.theisblog.com/36472573/tirzepatide-a-promising-new-treatment-for-obesity